<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>5(4)</volume><submitter>Xiang H</submitter><pubmed_abstract>Tobacco (&lt;i>Nicotiana tabacum&lt;/i>) plants synthesize the psychoactive pyridine alkaloid nicotine, which has sparked growing interest in reducing nicotine levels through genome editing aiming at inactivating key biosynthetic genes. Although stable transformation-mediated genome editing is effective in tobacco, its polyploid nature complicates the complete knockout of genes and the segregation of transgenes from edited plants. In this study, we developed a non-transgenic genome editing method in tobacco by delivering the CRISPR/Cas machinery via an engineered negative-strand RNA rhabdovirus vector, followed by the regeneration of mutant plants through tissue culture. Using this method, we targeted six &lt;i>berberine bridge enzyme-like protein&lt;/i> (&lt;i>BBL&lt;/i>) family genes for mutagenesis, whic</pubmed_abstract><journal>aBIOTECH</journal><pagination>449-464</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11624166</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Development of an RNA virus vector for non-transgenic genome editing in tobacco and generation of &amp;lt;i&amp;gt;berberine bridge enzyme-like&amp;lt;/i&amp;gt; mutants with reduced nicotine content.</pubmed_title><pmcid>PMC11624166</pmcid><pubmed_authors>Gao Q</pubmed_authors><pubmed_authors>Jiang J</pubmed_authors><pubmed_authors>Li Z</pubmed_authors><pubmed_authors>Wang S</pubmed_authors><pubmed_authors>Huang H</pubmed_authors><pubmed_authors>Mi Q</pubmed_authors><pubmed_authors>Xiang H</pubmed_authors><pubmed_authors>Ni S</pubmed_authors><pubmed_authors>Chen B</pubmed_authors><pubmed_authors>Zeng W</pubmed_authors><pubmed_authors>Kong W</pubmed_authors></additional><is_claimable>false</is_claimable><name>Development of an RNA virus vector for non-transgenic genome editing in tobacco and generation of &amp;lt;i&amp;gt;berberine bridge enzyme-like&amp;lt;/i&amp;gt; mutants with reduced nicotine content.</name><description>Tobacco (&lt;i>Nicotiana tabacum&lt;/i>) plants synthesize the psychoactive pyridine alkaloid nicotine, which has sparked growing interest in reducing nicotine levels through genome editing aiming at inactivating key biosynthetic genes. Although stable transformation-mediated genome editing is effective in tobacco, its polyploid nature complicates the complete knockout of genes and the segregation of transgenes from edited plants. In this study, we developed a non-transgenic genome editing method in tobacco by delivering the CRISPR/Cas machinery via an engineered negative-strand RNA rhabdovirus vector, followed by the regeneration of mutant plants through tissue culture. Using this method, we targeted six &lt;i>berberine bridge enzyme-like protein&lt;/i> (&lt;i>BBL&lt;/i>) family genes for mutagenesis, whic</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Dec</publication><modification>2025-04-04T23:31:36.119Z</modification><creation>2025-04-04T23:31:36.119Z</creation></dates><accession>S-EPMC11624166</accession><cross_references><pubmed>39650142</pubmed><doi>10.1007/s42994-024-00188-y</doi></cross_references></HashMap>